Functional regulation of the cardiac ryanodine receptor by suramin and calmodulin involves multiple binding sites.
Suramin and structurally related compounds increase not only the open probability (P(o)) of ryanodine receptor (RyR) channels but also the single-channel conductance in a unique characteristic manner. In this report, we examine the mechanisms underlying the complex changes to cardiac RyR channel function caused by suramin and the evidence that these changes result from an interaction with calmodulin (CaM) binding sites. In the presence of 100 microM cytosolic Ca(2+), we demonstrate that suramin exerts a triphasic effect on P(o), indicating the presence of high-, intermediate-, and low-affinity suramin binding sites. The effects of suramin binding to high-affinity sites are Ca(2+)-dependent; P(o) is decreased and seems to result from a reduction in the sensitivity of the channel to cytosolic Ca(2+). We suggest that this site is the CaM inhibition site. Suramin also binds to intermediate-affinity sites that mediate an increase in P(o) and an increase in conductance. Cytosolic Ca(2+) is not an absolute requirement for the effects mediated via intermediate-affinity suramin sites. The suramin-induced increase in P(o) and conductance are both concentration-dependent. The correlation between the increase in P(o) and increase in conductance indicates that the binding events which produce an increase in P(o) also lead to an increase in conductance and, because the effect is concentration-dependent, multiple suramin molecules must bind to produce the maximum effect. The low-affinity suramin binding sites are inhibition sites and mediate a reduction in P(o) caused by changes to both open and closed lifetimes.
Hill
Adam Parker
AP
Imperial College School of Medicine, National Heart & Lung Institute, London, United Kingdom.
Kingston
Olivia
O
Sitsapesan
Rebecca
R
D000818:Animals; D001665:Binding Sites; D002147:Calmodulin / Q000494:pharmacology*; D066298:In Vitro Techniques; D009206:Myocardium / Q000378:metabolism*; D012433:Ryanodine / Q000378:metabolism; D019837:Ryanodine Receptor Calcium Release Channel / Q000187:drug effects / Q000378:metabolism*; D012519:Sarcoplasmic Reticulum / Q000187:drug effects* / Q000378:metabolism; D012756:Sheep; D013498:Suramin / Q000494:pharmacology*
D002147:Calmodulin; D019837:Ryanodine Receptor Calcium Release Channel; D012433:Ryanodine; D013498:Suramin